GENE ONLINE|News &
Opinion
Blog

2021-08-26|

Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara

by Kathy Huang
Share To
With two COVID-19 vaccines gaining emergency use approvals, mRNA technology has come into focus over the past year. RNA technology encompasses a wide range of modalities and RNA editing is one among them. Although the technique is still being perfected and hasn’t become clinically viable, its high efficiency and safety over DNA editing is expected to make a splash in the near future.

We interviewed Professor Toshifumi Tsukahara, an expert in RNA editing to know more about the current challenges and future opportunities in the field.

It's free! Log in now to read

LATEST
Droughts and Floods Alter Phytoplankton Communities in the Yellow River Basin
2026-08-12
CDC Awards $3 Million to Louisiana Breast and Cervical Health Program for Cancer Screenings
2026-08-12
JAMA Pediatrics Study Finds Hospital-Wide Documentation of Curbside Consultations Improves Patient Safety
2026-08-12
iNaturalist Photographs Help Researchers Double Known Number of Harvestman Species Exhibiting Parental Care
2026-08-12
Integrating Fleet Data Streams Reduces Operational Inefficiencies in Pharmaceutical Logistics
2026-08-12
CEO Multidisciplinary Backgrounds Influence Corporate Maturity Mismatch Management
2026-08-12
Slotted Circumferential Groove Design Increases Transonic Compressor Rotor Stability
2026-08-12
Scroll to Top